5/23/2022  5:36:04 PM Chg. +0.010 Volume Bid5/23/2022 Ask5/23/2022 Market Capitalization Dividend Y. P/E Ratio
1.080EUR +0.93% 0
Turnover: 0.000
-Bid Size: - -Ask Size: - 45.7 mill.EUR 0.00% -

Business description

The biopharmaceutical company co.don AG based near Berlin is one of the leading specialists worldwide in cell cultivation for the regenerative treatment of articular cartilage defects and spinal disc defects. The company's patented pharmaceutical products are used to treat cartilage damage. Left untreated, cartilage defects can often result in joint replacement surgery.
 

Management board & Supervisory board

CEO
-
Management board
Dr. Achim Simons, Tilmann Bur
Supervisory board
Prof. Hans B. Bauerfeind, Thommy Stählin, Beatrix Bauerfeind-Johnson, Prof. Dr. Barbara Sickmüller, Prof. Dr. Hans-Jörg Bullinger, Thomas Krause
 

Company data

Name: Co.don AG
Address: Warthestraße 21,D-14513 Teltow
Phone: +49-3328-4346-0
Fax: +49-3328-4346-43
E-mail: info@codon.de
Internet: www.codon.de
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 12/31
Free Float: 41.56%
IPO date: 2/14/2001

Investor relations

Name: Matthias Meißner
IR phone: 49-30-2403-52-330
IR Fax: -
IR e-mail: ir@codon.de

Company calendar

CW 36 | 8/30/2022 Interim Report 2nd Quarter/6 Months
 

Main Shareholders

Bauerfeind Beteiligungsgesellschaft mbH
 
54.22%
Freefloat
 
41.56%
BBJ Beteiligungsgesellschaft mbH
 
4.22%